Checkmate Pharmaceuticals, Inc. CMPI
Day range unavailable
52-week range unavailable
CMPI free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-54,558,000 USD
FY 2021 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2021 | 2021-12-31 | -54,558,000 | -16,447,000 | Not meaningful |
| FY 2020 | 2020-12-31 | -38,111,000 | -11,260,000 | Not meaningful |
| FY 2019 | 2019-12-31 | -26,851,000 | -6,430,000 | Not meaningful |
| FY 2018 | 2018-12-31 | -20,421,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:03:17.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.